|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:CEO
|
gptkb:Steve_Chapman
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:founded
|
2004
|
|
gptkbp:founder
|
gptkb:Jonathan_Sheena
gptkb:Steve_Chapman
gptkb:Matthew_Rabinowitz
|
|
gptkbp:headquartersLocation
|
gptkb:Austin,_Texas,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Natera
|
|
gptkbp:industry
|
gptkb:biotechnology
genetic testing
|
|
gptkbp:numberOfEmployees
|
over 2,000
|
|
gptkbp:product
|
gptkb:Signatera
gptkb:Panorama
gptkb:Horizon
gptkb:Prospera
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:revenue
|
$820 million (2023)
|
|
gptkbp:specializesIn
|
non-invasive prenatal testing
cancer monitoring
cell-free DNA testing
organ transplant rejection assessment
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:NTRA
|
|
gptkbp:website
|
https://www.natera.com/
|
|
gptkbp:bfsParent
|
gptkb:Casdin_Capital
gptkb:Roelof_Botha
gptkb:San_Carlos,_California,_USA
gptkb:San_Carlos,_California,_United_States
gptkb:Sofinnova_Investments
gptkb:Sutter_Hill_Ventures
gptkb:Matthew_Rabinowitz
|
|
gptkbp:bfsLayer
|
6
|